Terms: = Ovarian cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
49 results:
1. Ascites exosomal lncRNA PLADE enhances platinum sensitivity by inducing R-loops in ovarian cancer.
Liu H; Deng S; Yao X; Liu Y; Qian L; Wang Y; Zhang T; Shan G; Chen L; Zhou Y
Oncogene; 2024 Mar; 43(10):714-728. PubMed ID: 38225339
[TBL] [Abstract] [Full Text] [Related]
2. NMR-identification of the interaction between Brca1 and the intrinsically disordered monomer of the Myc-associated factor X.
Epasto LM; Pötzl C; Peterlik H; Khalil M; Saint-Pierre C; Gasparutto D; Sicoli G; Kurzbach D
Protein Sci; 2024 Jan; 33(1):e4849. PubMed ID: 38037490
[TBL] [Abstract] [Full Text] [Related]
3. Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS.
Chao A; Huang HJ; Lin CY; Lee CH; Lin CH; Chao AS; Lai CH; Chang TC; Wu KY; Wu RC
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37655726
[TBL] [Abstract] [Full Text] [Related]
4. Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2).
Valdivia A; Vagadia PP; Guo G; O'Brien E; Matei D; Schiltz GE
J Med Chem; 2023 Jul; 66(14):9445-9465. PubMed ID: 37449845
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of potent NAMPT-Targeting PROTACs using FK866 as the warhead.
Zhang P; Wang W; Guo M; Zhou L; Dong G; Xu D; Sheng C
Bioorg Med Chem Lett; 2023 Aug; 92():129393. PubMed ID: 37369332
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of ovarian cancer.
Bi K; Cheng J; He S; Fang Y; Huang M; Sheng C; Dong G
J Med Chem; 2023 Jan; 66(1):1048-1062. PubMed ID: 36563407
[TBL] [Abstract] [Full Text] [Related]
7. Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.
Ackroyd SA; Arguello D; Ramos P; Mahdi H; ElNaggar A; Winer I; Holloway R; Krivak T; Jones N; Turner VG; Herzog T; Chu C; Brown J; Mantia-Smaldone G
Gynecol Oncol; 2023 Feb; 169():164-171. PubMed ID: 36333181
[TBL] [Abstract] [Full Text] [Related]
8. Disclosure of genetic risk to dating partners among young adults with von Hippel-Lindau disease.
Bond E; Yashar B; Else T; Osborne J; Marvin M
Fam Cancer; 2023 Apr; 22(2):203-215. PubMed ID: 35984582
[TBL] [Abstract] [Full Text] [Related]
9. Deubiquitylase OTUD6B stabilizes the mutated pvhl and suppresses cell migration in clear cell renal cell carcinoma.
Guo K; Wei Y; Wang Z; Zhang X; Zhang X; Liu X; Wu W; Wu Z; Zhang L; Cui CP
Cell Death Dis; 2022 Feb; 13(2):97. PubMed ID: 35110537
[TBL] [Abstract] [Full Text] [Related]
10. Histone deacetylase inhibitor induced pvhl-independent degradation of HIF-1α and hierarchical quality control of pvhl via chaperone system.
Ni J; Ni A
PLoS One; 2021; 16(7):e0248019. PubMed ID: 34329303
[TBL] [Abstract] [Full Text] [Related]
11. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or ovarian cancer, 2012-2019.
Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
[TBL] [Abstract] [Full Text] [Related]
12. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor vhl gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract] [Full Text] [Related]
13. Ultrasound Microbubble-Mediated vhl Regulates the Biological Behavior of ovarian cancer Cells.
Li C; Hu S; Yue Y
Ultrasound Med Biol; 2021 Mar; 47(3):723-732. PubMed ID: 33261909
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies.
Poojary M; Jishnu PV; Kabekkodu SP
Mol Diagn Ther; 2020 Oct; 24(5):537-555. PubMed ID: 32548799
[TBL] [Abstract] [Full Text] [Related]
15. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
16. Imaging Diagnosis of Von Hippel-Lindau Syndrome.
Xu N; Duan W; Zhang R; Yang B
J Craniofac Surg; 2019 Oct; 30(7):e674-e677. PubMed ID: 31574790
[TBL] [Abstract] [Full Text] [Related]
17. ovarian Steroid Cell Tumor in an Adolescent With Von Hippel-Lindau Syndrome: A Case Report and Review of the Literature.
Marques A; Portugal R
Int J Gynecol Pathol; 2020 Sep; 39(5):473-477. PubMed ID: 31433374
[TBL] [Abstract] [Full Text] [Related]
18. Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α.
Liu D; Li H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988076
[TBL] [Abstract] [Full Text] [Related]
19. Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway.
Szybowska M; Mete O; Weber E; Silver J; Kim RH
Endocr Pathol; 2019 Sep; 30(3):237-245. PubMed ID: 30772928
[TBL] [Abstract] [Full Text] [Related]
20. Combination of Sonographic Morphology Score and Tumor Markers for Detecting Postoperative Recurrent Pelvic ovarian Carcinoma: Compared With MRI Assessment.
Shen ZY; Shen AJ; Yang SL; Wu MF
Ultrasound Q; 2019 Mar; 35(1):45-53. PubMed ID: 30672869
[TBL] [Abstract] [Full Text] [Related]
[Next]
